Most recently, Mr. Nawana served as CEO of medical diagnostics company Alere Inc., prior to Alere, he spent 15 years at Johnson & Johnson primarily in its Medical Device & diagnostics segment. (healthpointcapital.com)
Nawana was most recently chief executive of medical diagnostics company Alere, overseeing its US$ 5.3 bn acquisition by Abbott Laboratories in 2017 (biotech-capital.com)
Prior to joining Oberon, David was Chief Financial Officer and Treasurer at VolitionRx (NYSE MKT: VNRX), a multi-national medical diagnostics company developing simple blood - based tests to accurately diagnose a range of cancers. (oberonsecurities.com)